Elanco CFO granted deferred stock units

Elanco Animal Health EVP and CFO Robert M. VanHimbergen received a small compensation-related award of deferred stock units.

Rhea-AI Filing Summary

Elanco Animal Health EVP and CFO Robert M. VanHimbergen received a small compensation-related award of deferred stock units. On this Form 4, he acquired 8.3201 deferred stock units tied to Elanco common stock, bringing his directly held deferred stock unit balance to 65.7467.

Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent, and will settle in cash or shares after employment ends or in a specified future year under the company’s Executive Deferral and Stock Match Plan.

Insider Trade Summary

Grant/Award: 8.3201 shares

Grant/Award 1 txn

Insider VanHimbergen Robert M

Role EVP and CFO

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	8.3201	$23.68	$197.02

Holdings After Transaction: Deferred Stock Units — 65.7467 contracts (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred stock units granted: 8.3201 units Reference share price: $23.6800 per unit Deferred stock units after grant: 65.7467 units +1 more

4 metrics

Deferred stock units granted 8.3201 units Award to EVP and CFO on 2026-04-17

Reference share price $23.6800 per unit Price per deferred stock unit in grant

Deferred stock units after grant 65.7467 units Direct holdings following transaction

Underlying common stock 8.3201 shares Common stock underlying granted units

Key Terms

Deferred Stock Units, cash equivalent, Executive Deferral and Stock Match Plan

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share of Company common stock"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

cash equivalent financial

"represents the right to receive one share of Company common stock or the cash equivalent"

Executive Deferral and Stock Match Plan financial

"in accordance with Executive Deferral and Stock Match Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Elanco Animal Health (ELAN) report for its CFO?

Elanco Animal Health reported that EVP and CFO Robert M. VanHimbergen acquired 8.3201 deferred stock units. This award is compensation-related and not an open-market stock purchase or sale, reflecting additional deferred exposure to Elanco’s common stock over time.

How many deferred stock units does the Elanco (ELAN) CFO hold after this Form 4?

After this transaction, Elanco’s EVP and CFO directly holds 65.7467 deferred stock units. These units track Elanco common stock value and will convert into cash or shares in the future under the company’s Executive Deferral and Stock Match Plan terms.

What does each deferred stock unit represent for Elanco (ELAN) insiders?

Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent. The value mirrors Elanco’s share price, giving executives equity-linked compensation that typically settles after employment ends or in a specified future year.

When will the Elanco (ELAN) CFO’s deferred stock units from this grant be settled?

The deferred stock units will settle in cash or Elanco common shares following termination of employment or during a specified future year. Settlement timing is governed by the company’s Executive Deferral and Stock Match Plan, which outlines when and how units are paid out.

Is the Elanco (ELAN) CFO’s Form 4 transaction a stock sale or open-market purchase?

No. The Form 4 shows a grant of 8.3201 deferred stock units as compensation, not an open-market sale or purchase. The units are derivative awards that convert into cash or shares later, rather than immediate trading of Elanco common stock in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/21/2026 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VanHimbergen Robert M

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	04/17/2026		A		8.3201		(2)	(2)	Common Stock	8.3201	$23.68	65.7467	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen	04/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)